Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > D. Kathleen Scott > Profile

D. Kathleen Scott

Affiliations

  • Chief Financial Officer at Ars Pharmaceuticals Inc. (SPRY), 2024-10-17
  • Director at Nkgen Biotech Inc. (NKGN), 2024-02-15
  • at Dermata Therapeutics Inc. (DRMA), 2024-01-06
  • Director at Conatus Pharmaceuticals Inc. (CNAT), 2019-11-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Ars Pharmaceuticals Inc.
 SPRY $6.24 8,250 Officer 8,250 2022-11-29 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Ars Pharmaceuticals Inc.
 SPRY $16.00 12,500 4,949 2024-10-16 Filing
Ars Pharmaceuticals Inc.
 SPRY $16.00 12,500 13,199 2024-08-20 Filing